Thank you for sharing. I wasn't familiar with how well respected the Cleveland Clinic was. I planned to spend a little time researching Dr. Daniel J. Lindner when I get the opportunity, but being associated with such a reputable clinic is encouraging.

While most of us are not excited about CYDY spending more money of preclinical trials at this point, I'm sure they would not do so without good reasoning (funding or license deal close and/or to increase value for a future agreement).

I'm still optimistic that they will announce a pleasant surprise in the financing arena before the shareholder meeting next week.